Crotamiton: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 16: Line 16:


<!--FDA-Labeled Indications and Dosage (Adult)-->
<!--FDA-Labeled Indications and Dosage (Adult)-->
|fdaLIADAdult======Condition1=====
|fdaLIADAdult=*For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.


* Dosing Information
=====Pruritus of skin=====
 
:* Dosage
 
=====Condition2=====
 
* Dosing Information
 
:* Dosage
 
=====Condition3=====
 
* Dosing Information
 
:* Dosage
 
=====Condition4=====
 
* Dosing Information
 
:* Dosage
 
<!--Off-Label Use and Dosage (Adult)-->
 
<!--Guideline-Supported Use (Adult)-->
|offLabelAdultGuideSupport======Condition1=====
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Non–Guideline-Supported Use (Adult)-->
|offLabelAdultNoGuideSupport======Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Pediatric Indications and Dosage-->
 
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
|fdaLIADPed======Condition1=====


* Dosing Information
* Dosing Information


:* Dosage
:* Massage gently into affected areas until medication is completely absorbed. Repeat as needed.
 
=====Condition2=====
 
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Off-Label Use and Dosage (Pediatric)-->
 
<!--Guideline-Supported Use (Pediatric)-->
|offLabelPedGuideSupport======Condition1=====
 
* Developed by:


* Class of Recommendation:  
:*LOTION: Shake well before using.


* Strength of Evidence:
=====Scabies=====


* Dosing Information
* Dosing Information


:* Dosage
:* Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Clothing and bed linen should be changed the next morning. A cleansing bath should be taken 48 hours after the last application.
 
|offLabelAdultNoGuideSupport======Pediculosis capitis=====
=====Condition2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Non–Guideline-Supported Use (Pediatric)-->
|offLabelPedNoGuideSupport======Condition1=====


* Dosing Information
* Dosing Information
Line 109: Line 37:
:* Dosage
:* Dosage


=====Condition2=====
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
<!--Contraindications-->
|contraindications=* Condition1
|contraindications=* Condition1


Line 268: Line 191:


<!--Administration and Monitoring-->
<!--Administration and Monitoring-->
|administration=* Oral
|administration=In Scabies: Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Clothing and bed linen should be changed the next morning. A cleansing bath should be taken 48 hours after the last application.
 
In Pruritus: Massage gently into affected areas until medication is completely absorbed. Repeat as needed.
 
LOTION: Shake well before using.
 
DIRECTIONS FOR PATIENTS WITH SCABIES:
 
    Take a routine bath or shower. Thoroughly massage Eurax cream or lotion into the skin from the chin to the toes including folds and creases.
    Put Eurax cream or lotion under fingernails after trimming the fingernails short, because scabies are very likely to remain there. A toothbrush can be used to apply the Eurax cream or lotion under the fingernails. Immediately after use, the toothbrush should be wrapped in paper and thrown away. Use of the same brush in the mouth could lead to poisoning.
    A second application is advisable 24 hours later.
    A 60 gram tube or bottle is sufficient for two applications.
    Clothing and bed linen should be changed the next day. Contaminated clothing and bed linen may be dry-cleaned, or washed in the hot cycle of the washing machine.
    A cleansing bath should be taken 48 hours after the last application
 


* Intravenous
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.


Line 326: Line 262:


<!--Brand Names-->
<!--Brand Names-->
|brandNames=* ®<ref>{{Cite web | title =  | url =  }}</ref>
|brandNames=Eurax
 
<!--Look-Alike Drug Names-->
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>


Revision as of 20:52, 3 October 2014

Crotamiton
Black Box Warning
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Deepika Beereddy, MBBS [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Black Box Warning

Title
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content

Overview

Crotamiton is a pesticide that is FDA approved for the treatment of scabies (sarcoptes scabiei) and for symptomatic treatment of pruritic skin. There is a Black Box Warning for this drug as shown here. Common adverse reactions include dermatitis, skin irritation.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

  • For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.
Pruritus of skin
  • Dosing Information
  • Massage gently into affected areas until medication is completely absorbed. Repeat as needed.
  • LOTION: Shake well before using.
Scabies
  • Dosing Information
  • Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Clothing and bed linen should be changed the next morning. A cleansing bath should be taken 48 hours after the last application.

Off-Label Use and Dosage (Adult)

Non–Guideline-Supported Use

Pediculosis capitis
  • Dosing Information
  • Dosage

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Crotamiton FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Contraindications

  • Condition1

Warnings

Title
See full prescribing information for complete Boxed Warning.
ConditionName:
  • Content
  • Description

Precautions

  • Description

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Crotamiton in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Crotamiton in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

Drug Interactions

  • Drug
  • Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Crotamiton in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Crotamiton during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Crotamiton with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Crotamiton with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Crotamiton with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Crotamiton with respect to specific gender populations.

Race

There is no FDA guidance on the use of Crotamiton with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Crotamiton in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Crotamiton in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Crotamiton in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Crotamiton in patients who are immunocompromised.

Administration and Monitoring

Administration

In Scabies: Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Clothing and bed linen should be changed the next morning. A cleansing bath should be taken 48 hours after the last application.

In Pruritus: Massage gently into affected areas until medication is completely absorbed. Repeat as needed.

LOTION: Shake well before using.

DIRECTIONS FOR PATIENTS WITH SCABIES: 

   Take a routine bath or shower. Thoroughly massage Eurax cream or lotion into the skin from the chin to the toes including folds and creases.
   Put Eurax cream or lotion under fingernails after trimming the fingernails short, because scabies are very likely to remain there. A toothbrush can be used to apply the Eurax cream or lotion under the fingernails. Immediately after use, the toothbrush should be wrapped in paper and thrown away. Use of the same brush in the mouth could lead to poisoning.
   A second application is advisable 24 hours later.
   A 60 gram tube or bottle is sufficient for two applications.
   Clothing and bed linen should be changed the next day. Contaminated clothing and bed linen may be dry-cleaned, or washed in the hot cycle of the washing machine.
   A cleansing bath should be taken 48 hours after the last application

Monitoring

There is limited information regarding Monitoring of Crotamiton in the drug label.

  • Description

IV Compatibility

There is limited information regarding IV Compatibility of Crotamiton in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

  • Description

Management

  • Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Crotamiton in the drug label.

Pharmacology

There is limited information regarding Crotamiton Pharmacology in the drug label.

Mechanism of Action

Structure

File:Crotamiton01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Crotamiton in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Crotamiton in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Crotamiton in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Crotamiton in the drug label.

How Supplied

Storage

There is limited information regarding Crotamiton Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Crotamiton |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Crotamiton |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Crotamiton in the drug label.

Precautions with Alcohol

  • Alcohol-Crotamiton interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Eurax

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject: 

 |Page Name=Crotamiton
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Crotamiton
 |Label Name=Crotamiton11.png

}}

{{#subobject: 

 |Label Page=Crotamiton
 |Label Name=Crotamiton11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Crotamiton&oldid=1029920"